Background: A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean clinical practice guidelines (CPGs), and explore strong recommendations based on low quality of evidence. Methods: Determinants used in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach among 34 CPGs which have reported both strength of recommendations and level of evidence were reviewed. Results: Five of 34 CPGs (14.7%) considered quality of evidence, benefits and harms, patients' values and preferences, and costs. And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants. Judgement table was not widely provided for use to translate evidence into recommendations. Eighty-two of 121 recommendations (67.8%, ranged 20.0% to 100.0%) among 11 CPGs using the same judgement scheme showed 'strong' strength of recommendations based on low or very low quality of evidence. Among 5 paradigmatic situations that justify strong recommendations based on low or very low evidence, situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations. Situation classified as 'uncertain benefit, certain harm' was 4.9%. Conclusion: There is a need to introduce and systematize an evidence-based grading system. Using judgement table to justify the strength of recommendations and applying the 5 paradigmatic situations mentioned above is also recommended in the near future.
INTRODUCTION
To minimize bias and help interpret the most suitable decisions at the point of care for users of clinical practice guidelines (CPGs), a standardized systematic approach to grade evidence and the strength of recommendations is important. 1 However, because several grading systems have shown inconsistency and wide variations to grade quality of evidence and recommendations, 2,3 it is difficult for guideline users to understand the message. Different grading systems include Grading of Recommendations Assessment, Development and Evaluation (GRADE), National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate Guideline Network (SIGN), and Centre for Evidence-Based Medicine, Oxford (CEBM) are used to give a clinical recommendation in a CPG which have an influence on the clinician's point of view and can significantly change clinician's decisions and clinical outcomes. 1 The GRADE is an emerging consensus on rating quality of evidence and strength of recommendations. GRADE provides an explicit, comprehensive, transparent, and pragmatic approach 4-6 and is increasingly being adopted by organizations worldwide. 7-9 Separating the judgements regarding the quality of evidence from judgements about the strength of recommendations is a critical and defining feature of this new grading system. 10, 11 The GRADE approach also provides a framework to move from evidence to the recommendation. 12- 15 The strength of recommendations 16-18 depends on estimates of magnitude of effect, 19-21 estimates of values and preference and their variability, 22 confidence in each of these estimates, and resource use 23, 24 considerations.
GRADE guidance allows five situations that justify strong recommendations in the face of low or very low confidence in estimates for critical outcomes. 7, 25 Despite GRADE guidance's warning against the transparent approach, World Health Organization (WHO) guidelines showed that approximately one-half of the recommendations were based on low or very low confidence. 26- 28 It raises concerns about whether GRADE is being optimally applied in the WHO guideline development process.
In Korea, few CPGs are trying to adopt GRADE. 29-33 They considered little bit different components to grade recommendations and utilize varied grading systems. Some guidelines considered only an evidence and there was lack of information on the resource use and patients' value and preferences mostly. There has been no review of factors or grading systems used to grade recommendations in Korea. Therefore, it is necessary to obtain a clear rationale for the adoption of the GRADE approach which is currently accepted worldwide through the analysis of the current situation, particularly the situation where strong recommendations are based on low evidence.
The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean CPGs, and explore strong recommendations based on low quality of evidence.
METHODS

Data source
To identify determinants used to make judgement for the strength of recommendations in Korea, 56 CPGs developed based on the academic societies that are listed in the Korean Medical Guideline Information Center (http://www.guideline.or.kr/) were included. Of the 56 CPGs, 27 (48.2%) were developed between 2001 and 2010, and 29 (51.8%) were developed between 2011 and the end of June 2017. Fifty-six CPGs were developed in a total of 33 academic societies; 22 of 33 academic societies (66.7%) developed 1 CPG, 6 of 33 (18.2%) developed 2 CPGs, and 5 of 33 (15.1%) developed 3 or more CPGs.
Data abstraction process
We conducted 3-step process. First, 56 Korean CPGs were classified by reporting level of evidence and/or the strength of recommendations. Second, determinants used to make judgement for the strength of recommendations among 34 CPGs were identified (Appendix 1). The following determinants used GRADE approach worldwide is included: quality of evidence, balance between benefits and harms, patients' values and preferences, and costs (resource use). And additional determinants include absolute magnitude of effect and feasibility (Appendix 2). To collect data on feasibility, we considered two aspects, feasible to implement and whether to consider barriers. Third, to explore the strength of recommendations based on low or very low quality of evidence, 11 CPGs using the same judgement scheme (strong, weak) were reviewed. 29- 39 We will compare a summary on the strength of recommendations by low or very low quality of evidence with WHO CPGs. 7,26 Fourth, classification by 5 paradigmatic situations that justify strong recommendations based on low or very low certainty of the evidence in GRADE approach was performed. In case of 'life-threatening situations and potential equivalence' and 'one option is clearly less risky or costly,' the strength of the recommendation in favor of the intervention can be given a strong. In case of 'uncertain benefit with certain harm,' 'potential catastrophic harm,' and 'high similar benefits, one option potentially more risk or costly,' the strength of the recommendation against the intervention can be given a strong (Appendix 3).
RESULTS
Classification on reporting for the strength of recommendations and/or level of evidence among 56 Korean CPGs were as follows: 18 of 56 CPGs (32.1%) did not report both strength of recommendations and level of evidence, 2 CPG (3.6%) reported level of evidence only, 2 CPG (3.6%) reported strength of recommendations only, and 34 CPGs (60.7%) reported both strength of recommendations and level of evidence ( Strength of recommendations based on low quality of evidence among 11 Korean CPGs using the same judgement scheme (strong, weak, or conditional) were as follows: 82 of 121 recommendations (67.8%, ranged 20.0% to 100.0%) showed 'strong' strength of recommendations based on low or very low quality of evidence. Six of 11 CPGs (54.5%) made judgement 'strong' for more than 70% of recommendations based on low or very low quality of evidence ( Table 3) . The determinants used to make judgement varied among 11 CPGs (Appendix 1). Table 4 showed comparison a summary on the strength of recommendations by low or very low quality of evidence. Sixty-seven point eight % of recommendations was given 'strong' recommendations based on low or very low quality of evidence in 11 Korean CPGs, follows 67.4% for 44 CPGs of 20 countries, 53.0% for 43 CPGs of WHO, and 48.4% for 8 CPGs (human immunodeficiency virus [HIV] and tuberculosis [TB] only) of WHO. It was ranged from 57.8% to 74.5% for low quality of evidence and ranged from 27.6% to 57.8% for very low quality of evidence.
Classification by 5 paradigmatic situations that justify strong recommendations based on low or very low certainty of the evidence is shown in Table 5 . Situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations; 86.8% (66 of 76) in low quality of evidence and 100% (6 of 6) in very low quality of evidence. Situation classified as 'uncertain benefit and certain harm' was 4.9% (4 of 82 recommendations), and 7.3% (6 of 82) was classified as other situation including no intervention. 
DISCUSSION
Determinants used to justify the strength of recommendations among Korean CPGs were identified and classified. Five different grading systems each considered different factors; 1) only quality of evidence was considered, 2) quality of evidence and benefits and harms were considered, 3) quality of evidence, benefits and harms, and patients' values and preferences were considered, 4) quality of evidence, benefits and harms, and cost were considered, and 5) quality of evidence, benefits and harms, patients' values and preferences, and cost were considered. We also considered additional factors including absolute magnitude of effect and feasibility. GRADE approach has been adopted by 5 of 34 CPGs (14.7%). And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants ( and information in background on the determinants for making judgement the strength of recommendations ( Table 2) . To overcome these shortcomings, we should adopt a systematic and transparent GRADE approach which is used by many organizations and associations worldwide. We also reviewed current situation regarding strong recommendations based on low or very low quality of evidence among Korean CPGs. Lower percentage of 'strong' recommendations in very low quality of evidence (31.6% vs. 57.8% in 20 countries) is shown in Table 4 .
Alexander et al. 27,28 explained the reason why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. The main reason was limitations in their understanding and optimal application of GRADE. To utilize GRADE approach consistent with GRADE guidance, it requires training of guideline developers or panelists and formal processes to maximize adherence to GRADE principles. 7 GRADE guidance present five paradigmatic situations that justify strong recommendation based on low or very low certainty of the evidence (Appendix 3). 25,27 Among 5 paradigmatic situations, situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations. Situation classified as 'uncertain benefit and certain harm' was 4.9% (4 of 82). There was no recommendation classified as 'life-threatening situation' on the strong recommendations in favor of the intervention, and there was no recommendation classified as 'potential catastrophic harm,' and 'high similar benefits, one option potentially more risk or costly' on the strong recommendations against the intervention. Especially, when guideline developers have to make a decision the strong recommendation based on low evidence, it will be better to consider the five paradigmatic situations mentioned above.
Limitations for carrying out this study are as follow: First, since only 56 CPGs in the Korean Medical Guideline Information Center are analyzed among all Korean CPGs, there was lack of representative. At the end of 2013, 115 CPGs were reported to have been developed by 45 societies and organizations. 40 Second, 34 Korean CPGs were using different grading systems. Therefore, we performed data abstraction on the 11 CPGs using the same judgement scheme (strong, week or conditional), because we could not explore judgement of strong recommendation based on low or very low level of evidence for all CPGs included in the study. Third, when extracting the factors considered in the recommendation grading, we classified them based on the information provided in the method part. However, there were many cases in which the background part of the recommendation actually provided information that considers other factors. We summarized the two kinds of information in Appendix 1 because there are differences according to whether classification of factors considered in grading recommendation is based on information of method part or information of background part.
In conclusion, there were several grading systems with wide variations to grade quality of evidence and strength of recommendations, and strong recommendations based on low or very low quality of evidence were very common among Korean CPGs. There is a need to introduce and systematize an evidence-based grading system. It is also necessary to aggressively review, apply, and disseminate the worldwide GRADE approach that grades recommendations in consideration of important factors including quality of evidence, benefits and harms, patients' value and preferences, and cost in Korea. Before applying and disseminating the GRADE approach on rating quality of evidence and strength of recommendations in Korea, it is necessary to study what external and internal barriers are to use this grading system in advance. Judgement table was not widely provided for use to translate evidence into recommendations, and the five paradigmatic situations were not used against low evidences to decide strength of recommendations to be made. ☐ Large effect in the long term
The larger the potential effects and for longer periods of time, the more likely to have a strong recommendation.
☑ Small effect for short duration
Balance of benefits versus disadvantages
Benefits should consider the intended effects of the intervention.
☐ Benefits clearly outweigh disadvantages
Disadvantages should consider the potentially negative effects of the intervention, as well as the unintended effects.
☑ Benefits and disadvantages are balanced
The less potentially negative effects, the more likely to have a strong recommendation. ☐ Disadvantages clearly outweigh benefits Resource use
The resource needed for implementing the recommendation may comprise financial resources, human resources, and infrastructure or equipment. Ideally, the benefits of the intervention should come at reasonable, affordable and sustainable costs. One should consider that capital costs, such as for infrastructure development, even if initially high, may yield benefits in the long run.
☑ Less resource intensive
The higher the incremental or recurrent costs, all other things being equal, the less likely it is to have a strong recommendation.
☐ More resource intensive Feasibility All interventions require political commitment and wide stakeholder engagement as a prerequisite. In addition, "technical" feasibility requires functional organizational and institutional structures necessary to manage, follow through, and monitor the implementation of the recommendation. The elements of technical feasibility vary widely by country or context, but if these elements are likely to be functional in a wide variety of settings, the more likely is to have a strong recommendation. 
